Medtronic plc (NYSE:MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of robotic guidance systems, have entered into a definitive merger agreement under which Medtronic will acquire all outstanding ordinary shares of Mazor for a total of approximately $1.64 billion in cash, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired, as detailed in the press release issued by the companies. The acquisition is expected to close during Medtronic's third fiscal quarter ending January 25, 2019, subject to the satisfaction of customary closing conditions including receipt of regulatory clearances and approval by Mazor's shareholders.